284542
Potential impact of eliminating the tax subsidy of food and beverage television advertising directed at children and adolescents on BMI, dalys and healthcare costs in the United States
Tuesday, November 5, 2013
: 11:10 a.m. - 11:30 a.m.
Michael W. Long, SD,
Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA
Zachary Ward, MPH,
Center for Health Decision Science, Harvard School of Public Health, Boston, MA
Stephen Resch, Ph.D.,
Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA
Y. Claire Wang, MD, ScD,
Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY
Marj L. Moodie, DrPH,
Deakin Health Economics, Deakin Population Health, Deakin University, Burwood, Victoria, Australia
Robert C. Carter, PhD,
Deakin Health Economics, Deakin Population Health, Deakin University, Burwood, Victoria, Australia
Gary Sacks, PhD,
WHO Collaborating Centre for Obesity Prevention, Deakin University, Burwood, Victoria, Australia
Boyd Swinburn, PhD,
WHO Collaborating Centre for Obesity Prevention, Deakin University, Burwood, Victoria, Australia
Steven L. Gortmaker, PhD,
Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA
Introduction: Research indicates that food and beverage television (TV) advertising contributes to childhood obesity. The current tax treatment of advertising as an ordinary business expense serves to subsidize marketing of nutritionally-poor foods and beverages to children. Reducing exposure to TV ads by modifying the tax treatment of advertising expenses may be a promising intervention strategy. Methods: Using best available evidence, we modeled the effect of a national intervention after one year of implementation that eliminates the tax subsidy of advertising nutritionally-poor foods and beverages on TV to children ages 2-19. We adapted the Assessing Cost Effectiveness methodology to the U.S., using Medical Expenditure Panel Survey data on costs, and assessing effects on BMI and related disease rates for a simulated cohort of the 2005 U.S. population. We assumed maintenance of the BMI reduction; costs and DALYs are discounted at 3.5% annually. Results: We estimate the intervention would reduce mean per-child BMI by 0.49 (95% uncertainty interval (UI): 0.39; 0.59), avert an estimated 2.6M (95% UI: 1.3M-4.4M) Disability Adjusted Life Years (DALY) and cost an estimated $USD755,200 (95% UI: 433,000-1,151,000) per year. Reductions in BMI-related disease would result in an estimated $USD19.6 B (95% UI: 11.1-28.6B) reduction in discounted cost offsets over the life of the cohort, and save an estimated $25,900 for every dollar spent on the intervention. Discussion: Eliminating the tax subsidy of TV advertising costs for nutritionally-poor foods and beverages advertised to children and adolescents could lead to a cost saving intervention that could substantially reduce healthcare expenditures.
Learning Areas:
Biostatistics, economics
Public health or related public policy
Public health or related research
Systems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Describe the usefulness of cost effectiveness analysis to evaluate and compare childhood obesity prevention strategies
Identify methods for identifying cost effectiveness results of childhood obesity prevention efforts
Identify the comparative cost effectiveness between 4 childhood obesity prevention strategies
Keyword(s): Obesity, Cost-Effectiveness
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am a behavioral scientist and public health researcher with extensive experience in the treatment of childhood obesity. I am interested in obesity prevention and have published several papers related to TV viewing and obesity.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.